Top 15 Biotechnology Angel Investors in Japan (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Koki Yabu
Angel
|
2 | Japan | Angel, Pre-Seed | Content, Finance, Data Mining | $1.7M–$3M |
|
Aso Kaname
Angel
|
1 | Japan | Seed | Organic, Residential, Waste Management | |
|
Kengo Suzuki
Angel
|
1 | Japan | Seed, Pre-Seed | EdTech, Education, Metaverse | $194k–$610k |
|
Shoji Okamoto
Angel
|
1 | Japan | Seed | Lifestyle, Life Science, Service Industry | |
|
Mr Maru
Angel
|
1 | Japan | Seed | Organic, Residential, Waste Management | |
|
Shoji Miyata
Angel
|
1 | Japan | Seed, Series A | Travel, Organic, Software | $764k–$11M |
|
Hiroaki Kitano
Angel
|
1 | Japan, United States | Seed, Angel | Health Care, Fitness, Medical | $3.3M–$43M |
|
Hirofumi Miki
Angel
|
1 | Japan | Seed, Angel, Pre-Seed | Content, Internet, Marketing | $764k–$16M |
|
Kenshin Fujiwara
Angel
|
1 | Japan | Seed, Series A | Mobile, Medical, Software | |
|
Yutaka Matsuo
Angel
|
1 | Japan | Seed, Angel | Artificial Intelligence, SaaS, Robotics | |
|
Kamata Tomihisa
Angel
|
1 | Japan, United States | Seed, Angel | Fitness, Medical, Genetics | |
|
Yuriko Minami
Angel
|
1 | Japan | Series A, Seed, Pre-Seed | Medical, Biotechnology, SNS | $3M–$4.7M |
|
Yasunori Kaneko
Angel
|
1 | Japan | Seed | Biotechnology | |
|
Sakano Atsushi
Angel
|
1 | Japan | Seed, Series B | Medical, Nursing and Residential Care, SaaS | |
|
Hidetoshi Takano
Angel
|
1 | Japan, United States | Seed, Angel | Internet, Information Technology, Content | $455k–$30M |
| Access all 14 angel investors in Japan Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Koki Yabu is Founder, President & CEO at Mobcast inc.
Show more...Investment focus
- Industry: Content, Finance, Data Mining
- Stage:Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 3
- Round size: Angel $1.7M–$3M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Mobcast Group — mobcast is a sports entertainment company that operates a mobile entertainment platform for smartphones and feature phones. It supports customers with social game and social media services. The company was founded in 2009 and is based in Tokyo, Japan. Currently, it operates as a subsidiary of mobcast Inc.
- SmartApp Japan — Smart Apps is a developer of a blockchain services application designed for smartphones. The company's application uses cryptocurrency technology to offer token issuance, initial coin offering and dApps design support, providing a launchpad for start-up blockchain-related businesses.
Aso Kaname
Show more...Investment focus
- Industry: Organic, Residential, Waste Management
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AlgaleX — AlgaleX is a food technology and biotechnology company that develops AI-powered algae fermentation technology to produce sustainable food ingredients, nutritional compounds, and bioproducts. The company leverages proprietary AI-driven cultivation and fermentation systems to convert underutilized food byproducts into high-value microalgae rich innutrients such as DHA, umami compounds, and other functional ingredients. Its mission is to build a circular bioeconomy by reducing food waste while providing sustainable alternatives to marine- and animal-derived ingredients.The company's core technology is Touji-24, an AI-powered algae cultivation and fermentation control system that automates and optimizes microalgae production. Using proprietary fermentation processes and food byproducts such as awamori lees, AlgaleX cultivates algae that can be used to produce Umamo, a plant-based ingredient combining seafood-like umami flavor with high concentrations of DHA. This approach reduces reliance on wild-caught fish as a source of omega-3 fatty acids while upcycling food industry byproducts into valuable nutritional ingredients.
Kengo Suzuki is the Co-Founder of Glocalink Singapore. Kengo attended The University of Tokyo.
Show more...Investment focus
- Industry: EdTech, Education, Metaverse
- Stage:Seed, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 4
- Round size: Seed $194k–$610k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MoonJapan — MoonJapan is an educational impact startup that offers a variety of programs and thorough assistance.
- Memory Lab — Memory Lab is a research laboratory that offers AI paper analysis and development solutions.
- ElevationSpace — ElevationSpace offers high quality & well equipped workspaces giving tenants a nurturing environment .
Shoji Okamoto is the President of Mirai Works.
Show more...Investment focus
- Industry: Lifestyle, Life Science, Service Industry
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Monoun — Mono.un provides users with opportunities to meet authors and collaborate on tales and specializes in bringing exciting experiences full of stories of Japanese culture to the world.
- Memory Lab — Memory Lab is a research laboratory that offers AI paper analysis and development solutions.
Mr. Maru
Show more...Investment focus
- Industry: Organic, Residential, Waste Management
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AlgaleX — AlgaleX is a food technology and biotechnology company that develops AI-powered algae fermentation technology to produce sustainable food ingredients, nutritional compounds, and bioproducts. The company leverages proprietary AI-driven cultivation and fermentation systems to convert underutilized food byproducts into high-value microalgae rich innutrients such as DHA, umami compounds, and other functional ingredients. Its mission is to build a circular bioeconomy by reducing food waste while providing sustainable alternatives to marine- and animal-derived ingredients.The company's core technology is Touji-24, an AI-powered algae cultivation and fermentation control system that automates and optimizes microalgae production. Using proprietary fermentation processes and food byproducts such as awamori lees, AlgaleX cultivates algae that can be used to produce Umamo, a plant-based ingredient combining seafood-like umami flavor with high concentrations of DHA. This approach reduces reliance on wild-caught fish as a source of omega-3 fatty acids while upcycling food industry byproducts into valuable nutritional ingredients.
Shoji Miyata is the CEO of SmartHR.
Show more...Investment focus
- Industry: Travel, Organic, Software
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 5
- Round size: Seed $764k–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Morus — Morus is a university-based biotech startup developing functional food ingredients from silkworms to address global health and nutrition challenges.
- Epicbase — Epicbase is an AI-based automatic voice transcription service based on voice recognition technology.
- Somewhere — Somewhere is engaged in the travel and transportation business.
Senior Executive Vice President and CTO at Sony Group Corporation and President & CEO at Sony Computer Science Laboratories, Inc.. He attended Waseda University.
Show more...Investment focus
- Industry: Health Care, Fitness, Medical
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 8
- Round size: Seed $3.3M–$43M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GPx — GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts.
- AnotherBall — AnotherBall is a blockchain startup that combines entertainment and blockchain.
- SBX Corporation — AI R&D: Deep learning, Machine learning, Automation, Text mining. Development, customization and maintenance of software platforms for drug discovery and life science research.
After JTB Co., Ltd. and CYBIRD Co., Ltd. as an initial member of Glee Co., Ltd. is responsible for business development. Currently, he is mainly engaged in venture support in the Internet area, investing in venture and venture capital, and served as management advisor for dozens of companies. Hands-on business development, growth strategydevelopment, financing advice, HR organization design support, partner referral and Recruit Support. He is also engaged in business support for ventures in the healthcare and university venture fields. He served as Digital Health Meetup Advisor, NEDOTCP Mentor and Future 2016 Mentor.
Show more...Investment focus
- Industry: Content, Internet, Marketing
- Stage:Seed, Angel, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 27
- Round size: Seed $764k–$16M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Shiftus — Shiftus is a communication application that can be used in various part-time job sites such as cafes, izakayas, hotels, supermarkets
- Flagellin — Flagellin is a pharmaceutical and medical industry.Development and sales of SaaS that supports sales and marketing of database and analysis services in the pharmaceutical and medical industries
- Giver Take All — Gibber Take All is a Planning, development and management of business sharing platform
Kenshin is a CEO at Hacarus Inc., a healthcare technology startup based in Kyoto, Japan.He co-founded several tech startups with 2 exits in the past 15 years. His first career started as an engineer at Sony Computer Entertainment and worked on PlayStation development projects. HIs fist startup was acquired by Japanese public company, and thesecond startup was sold to the US company.Born in 1976. He holds a Computer Science degree from California State University. He loves mountain hiking and currently living in Kyoto Japan with his wife and family.
Show more...Investment focus
- Industry: Mobile, Medical, Software
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Helpfeel — Our vision is to make saving, sharing, and exploring ideas as natural as breathing. On this journey we're humbled to be helping millions around the world from solo makers to university research labs, from gamers to pro designers, and large to small teams like ours.
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
1997 Graduated from Tokyo University, Department of Electronic and Information Engineering. In 2002, he completed the doctoral program at the same graduate school. Ph.D. (Engineering) He was a researcher at the Institute of Industrial Science and Technology since the same year. After working as a visiting researcher at Stanford University in August2005, Associate Professor of Technology Management Strategy, Institute of Research, Graduate School of Engineering, University of Tokyo in 2007. Co-Representative, Associate Professor, Global Consumption Intelligence Donation Course, Department of Technology Management Strategy, Graduate School of Engineering, Tokyo University. Professor from 2019, Graduate School of Engineering, Tokyo University of Engineering, Department of Technology Management Strategy. He specializes in artificial intelligence, web mining, big data analytics. The Society of Artificial Intelligence received the Paper Award (2002), the 20th Anniversary Project Award (2006), the Field Innovation Award (2011), and the Merit Award (2013). At the Society of Artificial Intelligence, he has been a student editorial committee and an editorial committee, and vice chair/director since 2010. Chairman of Ethics from 2014 to 2018. Chairman of Japan Deep Learning Association since 2017.
Show more...Investment focus
- Industry: Artificial Intelligence, SaaS, Robotics
- Stage:Seed, Angel
- Geography: Japan
Investor stats
- Total investments: 6
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Jizai — Jizai is a provider of artificial intelligence technology, offering AI solutions, software-as-a-service products powered by AI, and robots that utilize AI capabilities for businesses across various industries. The company focuses on generative AI, large language models (LLMs), and robotics, offering customizable AI platforms and automation tools.It also engages in AI consulting and research collaborations.
- MemoriaPet — Memoria Pet operated by Next Paradigm 2 Co., Ltd. Creates full-color 3D-printed pet figurines from a single uploaded photo. Uses AI to generate 3D models, followed by full-color 3D printing.
- Tsunagari AI — Tsunagari specializes in developing and providing AI-powered consultation services tailored for local governments, aiming to enhance administrative efficiency, support citizen engagement, and streamline public service delivery.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dr. Kamada earned his Ph.D. at the University of Tokyo. In 1984, he pursued his journey to establish his own business that focused on information appliances and mobile software, namely ACCESS Co., Ltd.. With great success, the company entered the Tokyo Stock Exchange Mothers Market in 2001. He left ACCESS Co., Ltd. in 2011, and founded TomyK Ltd.in 2012 where he supports startups possessing revolutionary business ideas that revitalize the Japanese economy.
Show more...Investment focus
- Industry: Fitness, Medical, Genetics
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SmarTrial — Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan.
- Genomelink — Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
- MinD in a Device — MinD in a Device Co., Ltd. is a university-launched venture that aims to port human consciousness to devices (machines and computers) in the medium to long term based on long-term research results on consciousness. As the first step toward realization, we will evolve and deepen the "generation model" considered to be the source ofconsciousness, and promote the development of next-generation AI and social implementation.
Yuriko Minami is the Capitalist at Mirai Sozo Organization.
Show more...Investment focus
- Industry: Medical, Biotechnology, SNS
- Stage:Series A, Seed, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 6
- Round size: Series A $3M–$4.7M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- digzyme — Digzyme develops new enzymatic processes using bioinformatics. The company automates various stages of analysis related to the development of enzymes and bioprocesses using their core bioinformatics technology and further optimize using accumulated data.
- Varinos — Varinos is a clinical laboratory contract analysis company that is a partner of medical institutions. Varinos provides genomic testing development and contract analysis services using the latest technology, the next-generation sequencer.
- Metagen Therapeutics — Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access.
Yasunori has been involved in managing and financing US life sciences companies since 1981. He began his career at Genentech (NYSE: DNA), where he spearheaded its business development activities for the first several years. He was then Project Manager for the launch of Protropin (human growth hormone), the first product marketed by Genentech. In1987, he became head of corporate finance in the investment banking division of Paribas Capital Markets LTD in Tokyo, where he helped finance Japanese government agencies, municipalities and corporations in the Euro market. He also helped numerous life sciences companies raise capital. He then became Senior Vice President and CFO of Isis Pharmaceuticals (NASDAQ: ISIS), which went public during his tenure there. In 1992, he was recruited to be the original business executive at Tularik (acquired by Amgen in 2004), where at various times he was CFO and VP-Business Development until its public offering in 1999. He served on the board of LeukoSite until its merger with Millennium Pharmaceuticals (NASDAQ: MLNM) in 1999. He received an undergraduate degree from Keio University in Tokyo, a medical degree from Keio University School of Medicine, and an M.B.A. from Stanford Business School. He joined Skyline in 1999. He committed to golf several years ago after an unfortunate heading incident at a team reunion for his junior All-Star soccer team.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Logomix — Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas.
Sakano Atsushi
Show more...Investment focus
- Industry: Medical, Nursing and Residential Care, SaaS
- Stage:Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Heartseed — Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells.These spheroids are then surgically implanted into the heart to improve its performance.
- Matsuri Technologies — matsuri technologies is a real estate tech company that provides solutions to support private property rentals. The company's products include m2m Systems, an Airbnb management platform that helps business operators to manage their accounts, communicate with guests, automate check-ins, offer customer service, and more.
Joined Intelligence in 1999. Established Key Players Inc. in 2005. Consultation with more than 3,000 managers and career counseling for more than 10,000 individuals. In addition, we have invested in more than 55 outside directors, advisors and angels in Silicon Valley and Bangladesh in Japan. Over 100 lectures on careers, entrepreneurship andstartups.
Show more...Investment focus
- Industry: Internet, Information Technology, Content
- Stage:Seed, Angel
- Geography: Japan, United States
Investor stats
- Total investments: 42
- Round size: Seed $455k–$14M; Angel $4.3M–$30M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- D-Chain — D-Chain offers services related to IT development and production in the Web3 and Web2 fields.
- Rayout — Rayout is a business consulting company that provides creative content development, recruitment videos, and web production services.
- CAREER BIJIN — Career bijin is a total support company.
Biotechnology Angel investor funding in Japan at a glance
Stats across 10 deals from 14 investors.
Access all 14 angel investors in Japan Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 14 angel investors investing in Japan Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!